Hims & Hers stock price soars following weight loss drug deal
Source: Washington Examiner · Bias: Center Right
Summary
Shares of telehealth company Hims & Hers skyrocketed Monday after the company struck a deal with Danish drugmaker Novo Nordisk to sell its GLP-1 weight-loss medications, ending the feud between the companies. The agreement will allow Hims & Hers, which is popular for selling lifestyle medications directly to consumers, to avoid the regulatory problems it has encountered in […]
Related Coverage
- Big Oil heads for biggest profits in years as Trump pushes for lower gas prices (Right — New York Post)
- America 250 Soars With Amazing Flyovers and Aerial Action Over the National Mall (Right — RedState)
- This Republican Has a Wild Idea for Fixing Housing Prices: Let the Market Actually Work (Far Right — Townhall)
- Americans hit the road in record numbers for 4th of July — in spite of high gas prices (Right — New York Post)
- Iran threatens response without ‘full implementation’ of US deal (Center — The Hill News)
- Inside Carney’s Pipeline Deal with Alberta and BC (Far Left — The Tyee | BC's home for today's news, analysis and updates )
- Bessent on Trump accounts, gas prices and wage growth (Center — Politics - CBSNews.com)
- Lakers’ trade for Walker Kessler worth steep price — and needed to happen (Right — New York Post)
More Headlines From March 9, 2026
- Schumer calls on Trump to tap Strategic Petroleum reserve amid rising oil prices (Center)
- Live updates: Trump calls oil price surge ‘small price to pay’ as Iran names new leader (Center)
- Explosive thrown near NYC mayor's home being investigated as 'ISIS-inspired' terrorism, officials say (Center Left)
- National Average for Gallon of Gas Hits $3.54 Amid War in Iran (Center Left)
- Trump says he's "not happy" about Iran's new supreme leader (Center)






